Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?The Motley Fool • 12/14/23
How Pfizer's $43B acquisition of Seagen may impact Seattle and broader biotech marketGeekWire • 12/13/23
Midday Movers: Vertex Surges on Gene-Editing Deal, Pfizer Falls on Guidance MissInvestopedia • 12/13/23